UnitedHealth Group Incorporated
UNHNYSEHealthcare● Active
$399.47
+$3.00(+0.76%)
Market Cap$362.8B
P/E Ratio—
52W High$404.15
52W Low$234.6
UnitedHealth Group Incorporated (UNH) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
UNH · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 21, 2026EPS Actual
$7.23
Est. $6.58 · +9.9%
Revenue
$111.7B
Est. $109.4B · +2.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 21, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 3-Quarter EPS Beat Streak
UNH reports quarterly as a NYSE-listed Medical - Healthcare Plans company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.00
Rev. $0.01B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.00
Rev. Est.$0.01B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | $4.84 | — | — | — | $110.8B | — |
| ▲ Q2 FY2026 | Apr 21, 2026 | $6.58 | $7.23 | +9.9% | $111.7B | $109.4B | +2.1% |
| — Q1 FY2026 | Jan 27, 2026 | $2.10 | $2.11 | +0.5% | $113.2B | $113.8B | -0.5% |
| ▲ Q4 FY2025 | Oct 28, 2025 | $2.80 | $2.92 | +4.3% | $113.2B | $113.0B | +0.1% |
| ▼ Q3 FY2025 | Jul 29, 2025 | $4.45 | $4.08 | -8.3% | $111.6B | $111.5B | +0.1% |
| ▼ Q2 FY2025 | Apr 17, 2025 | $7.29 | $7.20 | -1.2% | $109.6B | $111.6B | -1.8% |
| ▲ Q1 FY2025 | Jan 16, 2025 | $6.74 | $6.81 | +1.0% | $100.8B | $101.6B | -0.8% |
| ▲ Q4 FY2024 | Oct 15, 2024 | $7.00 | $7.15 | +2.1% | $99.18B | $99.14B | +0.0% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
$4.84
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 21, 2026Beat
EPS Actual
$7.23
EPS Est.
$6.58
EPS Surpr.
+9.9%
Revenue
$111.7B
Q1 FY2026
Jan 27, 2026
EPS Actual
$2.11
EPS Est.
$2.10
EPS Surpr.
+0.5%
Revenue
$113.2B
Q4 FY2025
Oct 28, 2025Beat
EPS Actual
$2.92
EPS Est.
$2.80
EPS Surpr.
+4.3%
Revenue
$113.2B
Q3 FY2025
Jul 29, 2025Miss
EPS Actual
$4.08
EPS Est.
$4.45
EPS Surpr.
-8.3%
Revenue
$111.6B
Q2 FY2025
Apr 17, 2025Miss
EPS Actual
$7.20
EPS Est.
$7.29
EPS Surpr.
-1.2%
Revenue
$109.6B
Q1 FY2025
Jan 16, 2025Beat
EPS Actual
$6.81
EPS Est.
$6.74
EPS Surpr.
+1.0%
Revenue
$100.8B
Q4 FY2024
Oct 15, 2024Beat
EPS Actual
$7.15
EPS Est.
$7.00
EPS Surpr.
+2.1%
Revenue
$99.18B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $3.70 | $3.78 | $3.91 | 15 |
| Q3 FY2028 | $5.02 | $5.14 | $5.32 | 8 |
| Q2 FY2028 | $6.36 | $6.51 | $6.74 | 8 |
| Q1 FY2028 | $8.81 | $9.01 | $9.33 | 11 |
| Q4 FY2027 | $3.29 | $3.36 | $3.48 | 14 |
| Q3 FY2027 | $4.22 | $4.31 | $4.47 | 7 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $120B | $122B | $125B | 6 |
| Q3 FY2028 | $119B | $121B | $124B | 11 |
| Q2 FY2028 | $118B | $120B | $123B | 6 |
| Q1 FY2028 | $115B | $117B | $121B | 6 |
| Q4 FY2027 | $114B | $116B | $119B | 7 |
| Q3 FY2027 | $113B | $115B | $118B | 8 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 21, 2026 | +9.9% | $323.48 | $346.01 | +6.96% |
| ▲ Q1 FY2026 | Jan 27, 2026 | +0.5% | $351.64 | $282.70 | -19.61% |
| ▲ Q4 FY2025 | Oct 28, 2025 | +4.3% | $365.98 | $367.84 | +0.51% |
| ▼ Q3 FY2025 | Jul 29, 2025 | -8.3% | $282.12 | $261.07 | -7.46% |
| ▼ Q2 FY2025 | Apr 17, 2025 | -1.2% | $585.04 | $454.11 | -22.38% |
| ▲ Q1 FY2025 | Jan 16, 2025 | +1.0% | $543.42 | $510.59 | -6.04% |
| ▲ Q4 FY2024 | Oct 15, 2024 | +2.1% | $605.40 | $556.29 | -8.11% |
| ▲ Q3 FY2024 | Jul 16, 2024 | +2.3% | $515.37 | $548.87 | +6.50% |
Q2 FY2026+6.96%
Report Date
Apr 21, 2026
EPS Beat/Miss
+9.9%
Price Before
$323.48
Price After
$346.01
Q1 FY2026-19.61%
Report Date
Jan 27, 2026
EPS Beat/Miss
+0.5%
Price Before
$351.64
Price After
$282.70
Q4 FY2025+0.51%
Report Date
Oct 28, 2025
EPS Beat/Miss
+4.3%
Price Before
$365.98
Price After
$367.84
Q3 FY2025-7.46%
Report Date
Jul 29, 2025
EPS Beat/Miss
-8.3%
Price Before
$282.12
Price After
$261.07
Q2 FY2025-22.38%
Report Date
Apr 17, 2025
EPS Beat/Miss
-1.2%
Price Before
$585.04
Price After
$454.11
Q1 FY2025-6.04%
Report Date
Jan 16, 2025
EPS Beat/Miss
+1.0%
Price Before
$543.42
Price After
$510.59
Q4 FY2024-8.11%
Report Date
Oct 15, 2024
EPS Beat/Miss
+2.1%
Price Before
$605.40
Price After
$556.29
Q3 FY2024+6.50%
Report Date
Jul 16, 2024
EPS Beat/Miss
+2.3%
Price Before
$515.37
Price After
$548.87
Avg Beat Reaction-3.30%
Avg Miss Reaction-14.92%
Beat Rate6 / 8 quarters
Largest Move-22.38% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: UNH ends December
UnitedHealth Group Incorporated (UNH) most recently reported earnings on April 21, 2026 for Q2 FY2026, posting EPS of $7.23 — beating the analyst consensus of $6.58 by +9.9%. UNH has beaten EPS estimates for 3 consecutive quarters. The next UNH earnings date is expected around September 1, 2026.
Each quarter, investors track UNH earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. UNH revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
UNH's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
UNH earnings · 5 questionsUnitedHealth Group Incorporated's next earnings report is expected around September 1, 2026. UNH typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; UNH historically reports after market close (AMC).
UNH earnings datewhen is UNH earningsUNH next earnings datewhen does UNH report earningsUNH earnings calendar
▸ Source: FMP · UnitedHealth Group Incorporated SEC filings · US GAAP · UnitedHealth Group Incorporated SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026